Carna Biosciences, Inc

Carna Biosciences, a biotechnology company focusing on kinases as the important targets for the development of drugs to treat a variety of diseases, including cancer, inflammation, and neurological disorders, offers a wide range of kinase protein products all developed and manufactured in-house and assay services with extensive kinase targets for your research and development. Our biochemical assay services are boast of delivering highly reproducible quality data by employing only our in-house kinases which have passed our stringent QC and conducting experiments under the thoroughly managed assay system by skilled hands. Our cell-based assays which investigate your compounds binding activities generate...

Kinase proteins,tyrosine kinases,serine/threonine kinases,lipid kinases,biotinylated proteins,mobility shift assays,adp-glo(tm) assays,1mm atp assays,preincubation,mapk cascade panel,cell cycle panel,terget engagement assays,residence time analysis,ic50 determinations,% inhibition studies,protein protein interaction (ppi),raf dimerization,activity assays, diacylglycerol kinases (dgks),and egfr

Carna biosciences, inc operates in the Biotechnology research industry.

Carna biosciences, inc's revenue is 1m - 10m

Carna biosciences, inc has 11 - 50 employees.